Every approved medicine is available because people volunteered to participate in a clinical trial. Participants and healthy volunteers make priceless contributions to advances in medicine.
Every prescription medicine available must be evaluated in a series of clinical trials. Each of these phases is followed by a regulatory review and approval process.
Clinical trials can meet or exceed quality and safety standards when they have strong oversight. Sanofi adheres to Good Clinical Practice (GCP), an international ethical and scientific quality standard for designing and conducting clinical trials.
Sanofi supports specific activities and initiatives of Patient Advocacy Groups that are focused on improving care for participants who take part in clinical trials and supporting caregivers.